<DOC>
	<DOCNO>NCT01360541</DOCNO>
	<brief_summary>Radiofrequency ablation versus endoscopic surveillance management low grade dysplasia Barrett oesophagus : multicentric randomise control trial .</brief_summary>
	<brief_title>Radiofrequency Ablation Barrett Oesophagus With Low Grade Dysplasia</brief_title>
	<detailed_description>Background : The occurrence low grade dysplasia ( LGD ) Barrett oesophagus ( BE ) know pre-cancerous state . Current recommendation case LGD close endoscopic surveillance every 6 12 month continuous Proton pomp inhibitor ( PPI ) treatment . Endoscopic radiofrequency ablation ( RFA ) demonstrate efficient treatment eradicate high grade dysplasia ( HGD ) LGD BE . Main aim study : To demonstrate prevalence patient LGD 3 year RFA treatment low surveillance group . Patients &amp; Methods : French multicentric randomize controlled trial patient BE confirm LGD : RFA v endoscopic surveillance . 120 patient plan include least 40 patient randomize group . Primary endpoint : Prevalence LGD group 3 year randomization Secondary endpoint : - Prevalence LGD group 1 5 year randomization - Rate complete eradication BE 1 , 3 5 year randomization - Incidence HGD adenocarcinoma 3 , 5 year randomization - Rate complication RFA group randomization - Cost - efficacy comparison 2 strategy</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>BE certain LGD least one endoscopic biopsy sample BE maximal length 12cm ( Prague classification ≤ C12 ) BE minimal length 1cm circumferentially 3cm case unique zone ( Prague classification ≥ C1 C0M3 ) Patients age 18 80 year Patients ' consent study enrollment No contraindication general anaesthesia Patients ability take PPI oral medication Patient affiliate social security system No pregnancy active contraception woman age procreate In case previous endoscopic mucosal resection HGD BE : least one year surveillance 2 biopsy series LGD without HGD BE length &gt; 12cm &lt; 1cm circumferentially ( &lt; C1 ) &lt; 3cm focally ( &lt; M3 ) HGD adenocarcinoma need specific endoscopic surgical treatment Active peptic oesophagitis ( Savary III IV ) previous oesophagus cancer previous endoscopic destruction treatment photodynamic therapy plasma argon coagulation previous Heller surgery oesophagus stenosis oesophagus varix oesophagus pathology associate sclerodermia Severe coagulation disorder thrombopenia Anaesthesia contraindication ( ASA 4 ) Life expectancy &lt; 2 year Disability take PPI oral medication follow protocol surveillance schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Barrett oesophagus</keyword>
	<keyword>Low grade dysplasia</keyword>
	<keyword>Radiofrequency ablation</keyword>
</DOC>